NCT04427787 2021-09-05LOLAFondazione IRCCS Istituto Nazionale dei Tumori, MilanoPhase 2 Unknown69 enrolled
NCT03083210 2019-05-20Study of Lanreotide in Metastatic or Recurrent Grade I-II Hindgut NETSamsung Medical CenterPhase 4 Unknown28 enrolled